Siberian Serpentarium

Siberian Serpentarium, also known as the Siberian Herpetological Centre, is a specialized Russian facility established in 1989 in Novosibirsk, then part of the Soviet Union. Its work combines biological research, the breeding and maintenance of venomous snakes, extraction of snake venom, and the production of medicines derived from that venom. The organization is described in reference material as Russia’s only serpentarium and as one of the world’s largest, or the world’s largest, producers of snake venom. The facility originally worked with the common adder found in the Vasyugan Swamp. As demand developed for venoms from other species, its collection and breeding program expanded to snakes associated with the Altai, Far Eastern, and Central Asian regions. Species identified in reference material include the Halys viper, short-tailed viper, brown mamushi, Vipera libetina turanika, and Vipera raddei. This regional range gives the centre access to venoms with different biological properties and supports its research and pharmaceutical activities. Its operating model involves maintaining venomous snakes, breeding them in captivity, and periodically collecting venom. Wild-caught snakes may reportedly remain at the facility for as long as ten years, while the average survival period is described as more than three and a half years. These details indicate that the serpentarium functions not merely as a collection or exhibition site, but as a controlled biological-production and research operation. The centre produces snake venom in crystal and lyophilized forms. The cited reference material states that annual output is approximately 2,000 grams. It also produces snake-venom medications, including an anti-inflammatory ointment. The available material does not identify specific commercial product names, distribution agreements, corporate ownership, financial performance, or current management. It likewise does not establish a complete export footprint or a formal consumer-facing brand architecture. Siberian Serpentarium’s significance lies in the combination of specialized animal husbandry, venom harvesting, and applied biomedical production. Its identity is closely tied to Siberia and to the scientific use of regional snake species. Because public information about its legal structure, ownership, leadership, and present commercial operations is limited, the organization is best characterized as a specialized herpetological and biopharmaceutical facility rather than a conventional mass-market brand.

Siberian Serpentarium was founded in 1989 in Novosibirsk, during the Soviet period. It was created as a specialized centre for the study and controlled maintenance of venomous snakes, with activities extending into venom collection and medicinal production. The facility’s early work relied on the common adder found in the Vasyugan Swamp, linking its initial biological resources to the surrounding Siberian region. Over time, the centre broadened its collection and breeding activities in response to demand for venoms from additional species. Snakes from the Altai, Far East, and Central Asia were introduced into its program, including the Halys viper, short-tailed viper, brown mamushi, Vipera libetina turanika, and Vipera raddei. This expansion enabled the organization to work with a wider range of venom types and reinforced its role as a specialized supplier for research and pharmaceutical applications. The serpentarium’s husbandry model includes both breeding and the long-term maintenance of snakes obtained from the wild. Reference material indicates that some wild-caught animals may be kept for up to ten years, with average survival exceeding three and a half years. Such practices support repeated venom collection while requiring specialized care, handling, and biological monitoring. Its production activities include the extraction and preparation of snake venom in crystal and lyophilized forms. The cited description gives an approximate annual output of 2,000 grams. In addition to supplying venom, the centre produces snake-venom medicines, including an anti-inflammatory ointment. The available references do not provide a detailed chronology of product launches, organizational restructuring, ownership changes, or commercial partnerships. The facility is presented as Russia’s only serpentarium and as a leading global producer of snake venom. Its public profile has also been supported by scientific and media coverage concerning venom research and the practical risks of working with venomous snakes. However, the available source material does not document current executives, a formal corporate parent, a public listing, or a confirmed official web address. Further verification would be needed to describe its present legal entity, commercial reach, and product portfolio in greater detail.

• 1989

  Serpentarium founded in Novosibirsk

  [1]Siberian Serpentariumen.wikipedia.org

  Siberian Serpentarium was established in Novosibirsk, then within the Soviet Union, as a centre for venomous-snake research, breeding, venom extraction, and related production.

• Expansion beyond the local common adder

  [1]Siberian Serpentariumen.wikipedia.org

  The facility expanded from working primarily with the common adder of the Vasyugan Swamp to breeding and maintaining venomous snakes from the Altai, Far East, and Central Asian regions.

• Development of venom-derived medicines

  [1]Siberian Serpentariumen.wikipedia.org

  Alongside venom extraction, the centre developed snake-venom medicinal products, including an anti-inflammatory ointment.

A specialized Siberian research and production centre focused on venomous-snake breeding, venom extraction, and venom-derived medicinal products.

• Biological research material

  Snake venom

  The serpentarium extracts venom from captive-bred and maintained venomous snakes for biological research and pharmaceutical use. Its program covers several species associated with Siberia, the Russian Far East, the Altai, and Central Asia. Reference material describes production in both crystal and lyophilized forms, with annual output of approximately 2,000 grams.

• Pharmaceutical product

  Snake-venom medications

  The centre produces medicinal preparations derived from snake venom. The available description specifically identifies an anti-inflammatory ointment, but does not provide a product name, formulation details, regulatory status, packaging information, or distribution markets.

1. 1Siberian Serpentariumen.wikipedia.org